Study finds hydroxychloroquine linked to higher death rate in Covid-19 patients
The study evaluated 96,000 Covid-19 patients in 671 hospitals worldwide.
Copyright 2020 The Associated Press. All Rights Reserved.
A study by the University Hospital of Zurich and Harvard Medical School finds the controversial antimalarial drugs, hydroxychloroquine and a similar drug chloroquine, show no benefit against Covid-19.
According to the studyExternal link published on Friday in the Lancet, hospitalised patients taking a regimen of the antimalarial drugs had a higher mortality rate. Patients treated with one of the drugs had a mortality rate of 11.1%, compared with 9.3% for a control sample.
The study, which was led by researchers at Harvard Medical School and the University Hospital of Zurich, evaluated 96,000 Covid-19 patients in 671 hospitals worldwide. About 15,000 of them were treated with one of the antimalarial drugs with or without antibiotics (macrolides such as azithromycin and clarithromycin) at the onset of the disease.
More
More
Swiss Politics
Coronavirus: the situation in Switzerland
This content was published on
An overview of the latest Covid-related information in the Alpine nation.
The researchers also observed a four-fold increased risk of cardiac arrhythmia. Some 4-8% of patients treated with one of the antimalarial drugs experienced a new heart arrhythmia, compared to 0.3% for those who were not taking such treatment.
There is “no scientific evidence” of the effectiveness of hydroxychloroquine and chloroquine, said Frank Ruschitzka, head of the Department of Cardiology at the University Hospital of Zurich in a statementExternal link.
“Hydroxychloroquine and chloroquine should therefore no longer be used for Covid-19 before we have the results of further, currently ongoing randomised clinical studies.”
The antimalarial drugs have been surrounded by controversy after enthusiastic remarks by US President Donald Trump earlier this year that left some epidemiologists uneasy given the well-known risks of the drugs particularly for people with heart conditions.
Last week, President Trump indicated that he has been taking hydroxychloroquine as a preventative measure. The US Food and Drug Administration (FDA) granted the drug emergency use authorization earlier this year but European authorities have been less enthusiastic about the drug.
Some of the excitement and hope stemmed from some pre-clinical studies as well as anecdotal evidence that it improved patents’ recovery.
In Switzerland, 17 hospitals are currently participating in a World Health Organization (WHO) solidarity study to test the effectiveness of hydroxychloroquine.
More
More
Balancing hope and science in the search for a coronavirus cure
This content was published on
The debate surrounding the antimalarial drug hydroxychloroquine epitomises companies’ balancing act between hope and scientific realities.
One person consumes 4.8 megawatt hours of electricity
This content was published on
On average, the Swiss consume 4.8 megawatt hours of electricity per year. According to Velobiz.de, this is roughly equivalent to the amount generated by all 176 cyclists in the Tour de France during the entire race.
Outgoing ICRC chief in Ukraine defends neutrality amid war
This content was published on
Swiss national Jürg Eglin, outgoing head of the International Committee of the Red Cross in Ukraine, reflects on his tenure.
Green party leader criticises government’s neo-liberal policy
This content was published on
The Green Party delegates' meeting opened on Saturday morning in Vicques (JU) with a speech by party president Lisa Mazzone. Mazzone took particular aim at the Federal Council's policy towards the United States.
Working on Sundays is detrimental to well-being, says Swiss study
This content was published on
A study by the University of Bern shows that working on Sundays is detrimental to well-being and particularly affects women.
Safra Sarasin private bank and former asset manager sentenced
This content was published on
The Office of the Attorney General of Switzerland has fined private bank J. Safra Sarasin CHF3.5 million for aggravated money laundering. A former bank employee received a six-month suspended prison sentence.
JPMorgan to pay CHF270 million to settle 1MDB claims
This content was published on
JPMorgan Chase has agreed to pay CHF270 million to the Malaysian government to settle all issues related to its role in the 1MDB financial scandal.
Famine confirmed in Gaza for first time, says UN-backed report
This content was published on
Famine has been declared in a northern part of the Gaza Strip, according to the Integrated Food Security Phase Classification (IPC) system.
Zurich Airport ground handling staff to strike on Friday
This content was published on
Ground handling staff at Zurich Airport have announced a strike for Friday afternoon. According to a union, 200 jobs are at risk.
This content was published on
Philippe Lazzarini will step down as head of the United Nations Relief and Works Agency for Palestinian Refugees (UNRWA) at the end of his term in March, he announced on Thursday.
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.
Read more
More
Swiss hospitals lose up to CHF3 billion amid pandemic
This content was published on
Switzerland’s hospitals and clinics are facing a financial loss of between CHF1.7 billion and CHF2.9 billion due to the Covid-19 pandemic.
‘Anti-malaria drug can kill coronavirus’: Novartis chief
This content was published on
Swiss pharmaceutical giant Novartis believes the anti-malaria drug hydroxychloroquine offers one of the best hopes to combat coronavirus.
This content was published on
Swiss scientists and drug companies are playing an important role in the global effort to develop treatments or a vaccine for the virus.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.